Democratic Republic of Congo vs Morocco: Statin use vs. average non-HDL cholesterol levels
Democratic Republic of Congo
2.8
in 2018
Morocco
2.8
in 2018
Democratic Republic of Congo rank
163rd
Morocco rank
163rd
Statin use vs. average non-HDL cholesterol levels over time
- Democratic Republic of Congo
- Morocco
How they compare
Democratic Republic of Congo currently reports 2.8 against 2.8 in Morocco, a difference of 0.
Across all 39 years both countries report, Morocco has been ahead every year.
Democratic Republic of Congo ranks 163rd and Morocco ranks 163rd of 191 countries.
Morocco has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Democratic Republic of Congo | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.58 | 3.01 | 0.43 | Morocco |
| 1990s | 2.68 | 3.27 | 0.59 | Morocco |
| 2000s | 2.75 | 3.25 | 0.5 | Morocco |
| 2010s | 2.8 | 2.96 | 0.1556 | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Democratic Republic of Congo or Morocco?
- Democratic Republic of Congo, at 2.8 against 2.8 in Morocco as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Democratic Republic of Congo and Morocco?
- 0, with Democratic Republic of Congo ahead.
- How many years of comparable data are there for Democratic Republic of Congo and Morocco?
- 39 years are reported by both, from 1980 to 2018.
- How do Democratic Republic of Congo and Morocco rank globally for statin use vs. average non-hdl cholesterol levels?
- Democratic Republic of Congo ranks 163rd and Morocco ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.